Works by Kjeldsen, Sverre E.

Results: 282

Effect of dietary counselling on blood pressure and arterial plasma catecholamines in primary hypertension<sup>*</sup>.

Published in:

American Journal of Hypertension, 1995, v. 8, n. 7, p. 704, doi. 10.1016/0895-7061(95)00122-6

By:

Beckmann, Sissel L.;
Ingrid, O.S.;
Kjeldsen, Sverre E.;
Eide, Ivar K.;
Westheim, Arne S.;
Hjermann, Ingvar

Publication type:

Article

Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal women.

Published in:

American Journal of Hypertension, 1995, v. 8, n. 5, p. 439, doi. 10.1016/0895-7061(95)00044-P

By:

Nordby, Gudmund;
Moan, Andreas;
Kjeldsen, Sverre E.;
Os, Ingrid

Publication type:

Article

Insulin sensitivity, sympathetic activity, and cardiovascular reactivity in young men.

Published in:

American Journal of Hypertension, 1995, v. 8, n. 3, p. 268, doi. 10.1016/0895-7061(94)00206-Q

By:

Moan, Andreas;
Nordby, Gudmund;
Rostrup, Morten;
Eide, Ivar;
Kjeldsen, Sverre E.

Publication type:

Article

Fixed-Dose Combinations in the Management of Hypertension: Defining the Place of Angiotensin Receptor Antagonists and Hydrochlorothiazide.

Published in:

American Journal of Cardiovascular Drugs, 2005, v. 5, n. 1, p. 17, doi. 10.2165/00129784-200505010-00003

By:

Kjeldsen, Sverre E.;
Os, Ingrid;
Høieggen, Aud;
Beckey, Kim;
Gleim, Gilbert W.;
Oparil, Suzanne

Publication type:

Article

Losartan: A Viewpoint by Sverre E. Kjeldsen.

Published in:

American Journal of Cardiovascular Drugs, 2003, v. 3, n. 5, p. 378, doi. 10.2165/00129784-200303050-00009

By:

Sverre E. Kjeldsen

Publication type:

Article

Late outcomes of renal denervation are more favourable than early ones: facts or fancies?

Published in:

Clinical Kidney Journal, 2023, v. 16, n. 12, p. 2357, doi. 10.1093/ckj/sfad231

By:

Persu, Alexandre;
Stoenoiu, Maria S;
Maes, Frédéric;
Kreutz, Reinhold;
Mancia, Giuseppe;
Kjeldsen, Sverre E

Publication type:

Article

Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study.

Published in:

European Journal of Heart Failure, 2011, v. 13, n. 4, p. 384

By:

Okin, Peter M.;
Oikarinen, Lasse;
Viitasalo, Matti;
Toivonen, Lauri;
Kjeldsen, Sverre E.;
Nieminen, Markku S.;
Edelman, Jonathan M.;
Dahlöf, Björn;
Devereux, Richard B.

Publication type:

Article

Orthostatic hypertension: the forgotten phenotype.

Published in:

2024

By:

Palatini, Paolo;
Kjeldsen, Sverre E.;
Burnier, Michel

Publication type:

Abstract

Should treatment of 'elevated' blood pressure, especially in older people, be based on global risk estimation?

Published in:

Blood Pressure, 2024, v. 33, n. 1, p. 1, doi. 10.1080/08037051.2024.2430228

By:

Kjeldsen, Sverre E.;
Brunström, Mattias;
Burnier, Michel;
Egan, Brent;
Narkiewicz, Krzysztof;
Kreutz, Reinhold;
Mancia, Giuseppe

Publication type:

Article

Lowering of systolic blood pressure in hypertensive patients: insights and questions from the ESPRIT study.

Published in:

Blood Pressure, 2024, v. 33, n. 1, p. 1, doi. 10.1080/08037051.2024.2394448

By:

Kreutz, Reinhold;
Brunström, Mattias;
Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Egan, Brent;
Burnier, Michel

Publication type:

Article

Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases?

Published in:

Blood Pressure, 2024, v. 33, n. 1, p. 1, doi. 10.1080/08037051.2024.2329571

By:

Kjeldsen, Sverre E.;
Egan, Brent M.;
Burnier, Michel;
Narkiewicz, Krzysztof;
Kreutz, Reinhold;
Mancia, Giuseppe

Publication type:

Article

Effect of antihypertensive treatment in isolated systolic hypertension (ISH) – systematic review and meta-analysis of randomised controlled trials.

Published in:

Blood Pressure, 2023, v. 32, n. 1, p. 1, doi. 10.1080/08037051.2023.2226757

By:

Brunström, Mattias;
Carlberg, Bo;
Kjeldsen, Sverre E.

Publication type:

Article

Women's health, cardiovascular risk and hypertension: the perspective still needs to improve.

Published in:

Blood Pressure, 2023, v. 32, n. 1, p. 1, doi. 10.1080/08037051.2023.2193648

By:

Burnier, Michel;
Brguljan, Jana;
Algharably, Engi Abd Elhady;
Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Egan, Brent;
Oparil, Suzanne;
Kreutz, Reinhold

Publication type:

Article

TIME to face the reality about evening dosing of antihypertensive drugs in hypertension.

Published in:

Blood Pressure, 2023, v. 32, n. 1, p. 1, doi. 10.1080/08037051.2022.2142512

By:

Kjeldsen, Sverre E.;
Egan, Brent M.;
Narkiewicz, Krzysztof;
Kreutz, Reinhold;
Burnier, Michel;
Oparil, Suzanne;
Mancia, Giuseppe

Publication type:

Article

Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.

Published in:

Blood Pressure, 2022, v. 31, n. 1, p. 210, doi. 10.1080/08037051.2022.2110858

By:

Esler, Murray;
Kjeldsen, Sverre E.;
Pathak, Atul;
Grassi, Guido;
Kreutz, Reinhold;
Mancia, Giuseppe

Publication type:

Article

Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure.

Published in:

Blood Pressure, 2022, v. 31, n. 1, p. 207, doi. 10.1080/08037051.2022.2107483

By:

Narkiewicz, Krzysztof;
Kjeldsen, Sverre E.;
Egan, Brent M.;
Kreutz, Reinhold;
Burnier, Michel

Publication type:

Article

Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions.

Published in:

Blood Pressure, 2022, v. 31, n. 1, p. 164, doi. 10.1080/08037051.2022.2095254

By:

Egan, Brent M.;
Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Kreutz, Reinhold;
Burnier, Michel

Publication type:

Article

Thirty years with LIFE—a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy.

Published in:

Blood Pressure, 2022, v. 31, n. 1, p. 125, doi. 10.1080/08037051.2022.2083578

By:

Kjeldsen, Sverre E.;
Egan, Brent M.;
Narkiewicz, Krzysztof;
Kreutz, Reinhold;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Article

Hypertension management during the COVID-19 pandemic: what can we learn for the future?

Published in:

Blood Pressure, 2022, v. 31, n. 1, p. 47, doi. 10.1080/08037051.2022.2058909

By:

Burnier, Michel;
Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Egan, Brent;
Kreutz, Reinhold

Publication type:

Article

A 30th anniversary and a glimpse of the future.

Published in:

Blood Pressure, 2022, v. 31, n. 1, p. 1, doi. 10.1080/08037051.2021.2021638

By:

Burnier, Michel;
Kjeldsen, Sverre E.

Publication type:

Article

Attended vs. unattended blood pressure – learnings beyond SPRINT: European Society of Hypertension Scientific Newsletter No. 74.

Published in:

Blood Pressure, 2021, v. 30, n. 6, p. 439, doi. 10.1080/08037051.2021.1995981

By:

Kjeldsen, Sverre E.;
Grassi, Guido;
Kreutz, Reinhold;
Mancia, Giuseppe

Publication type:

Article

The five RADIANCE-HTN and SPYRAL-HTN randomised studies suggest that the BP lowering effect of RDN corresponds to the effect of one antihypertensive drug.

Published in:

Blood Pressure, 2021, v. 30, n. 6, p. 327, doi. 10.1080/08037051.2021.1995975

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Article

Combining proteomics, home blood pressure telemonitoring and patient empowerment to improve cardiovascular and renal protection.

Published in:

Blood Pressure, 2021, v. 30, n. 5, p. 267, doi. 10.1080/08037051.2021.1975878

By:

Narkiewicz, Krzysztof;
Burnier, Michel;
Kjeldsen, Sverre E.;
Oparil, Suzanne

Publication type:

Article

Cuff-less measurements of blood pressure: are we ready for a change?

Published in:

2021

By:

Burnier, Michel;
Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Oparil, Suzanne

Publication type:

Editorial

Better drug adherence improves blood pressure control and lowers cardiovascular disease outcomes – from single pill combinations to monitoring of a nationwide health insurance database.

Published in:

2021

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

In memoriam: Jiří Widimský Sr. 1925–2020.

Published in:

2021

By:

Kreutz, Reinhold;
Cífková, Renata;
Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne;
Mancia, Giuseppe

Publication type:

Obituary

Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk.

Published in:

Blood Pressure, 2021, v. 30, n. 2, p. 90, doi. 10.1080/08037051.2020.1856642

By:

Olsen, Eirik;
Holzhauer, Björn;
Julius, Stevo;
Kjeldsen, Sverre E.;
Larstorp, Anne Cecilie K.;
Mancia, Giuseppe;
Mehlum, Maria H.;
Mo, Rune;
Rostrup, Morten;
Søraas, Camilla L.;
Zappe, Dion;
Weber, Michael A.

Publication type:

Article

Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension.

Published in:

Blood Pressure, 2021, v. 30, n. 2, p. 82, doi. 10.1080/08037051.2020.1855968

By:

Olsen, Eirik;
Holzhauer, Björn;
Julius, Stevo;
Kjeldsen, Sverre E.;
Larstorp, Anne Cecilie K.;
Mancia, Giuseppe;
Mehlum, Maria H.;
Mo, Rune;
Rostrup, Morten;
Søraas, Camilla L.;
Zappe, Dion;
Weber, Michael A.

Publication type:

Article

Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers.

Published in:

2021

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

Smoking and overweight associated with masked uncontrolled hypertension: a Hypertension Optimal Treatment (HOT) Sub-Study.

Published in:

Blood Pressure, 2021, v. 30, n. 1, p. 51, doi. 10.1080/08037051.2020.1787815

By:

Holanger, Magnus;
Kjeldsen, Sverre E.;
Jamerson, Kenneth;
Julius, Stevo

Publication type:

Article

In memoriam: Peter Sleight 1929–2020.

Published in:

2020

By:

Kreutz, Reinhold;
Kjeldsen, Sverre E.;
Burnier, Michel;
Narkiewicz, Krzysztof;
Oparil, Suzanne;
Mancia, Giuseppe

Publication type:

Obituary

Was it optimal to drop a diuretic as a first-line choice of drug treatment in the 2020 International Society of Hypertension Guidelines?

Published in:

2020

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

The International Society of Hypertension Guidelines 2020 – a new drug treatment recommendation in the wrong direction?

Published in:

2020

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy.

Published in:

Blood Pressure, 2020, v. 29, n. 5, p. 319, doi. 10.1080/08037051.2020.1782171

By:

Okin, Peter M.;
Hille, Darcy A.;
Wachtell, Kristian;
Kjeldsen, Sverre E.;
Julius, Stevo;
Devereux, Richard B.

Publication type:

Article

Intensive systolic blood pressure control and prevention of new onset atrial fibrillation in the SPRINT study: is the association really controversial?

Published in:

2020

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project.

Published in:

2020

By:

Kreutz, Reinhold;
Kjeldsen, Sverre E.;
Burnier, Michel;
Narkiewicz, Krzysztof;
Oparil, Suzanne;
Mancia, Giuseppe

Publication type:

Editorial

How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers.

Published in:

2020

By:

Burnier, Michel;
Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Oparil, Suzanne

Publication type:

Editorial

The Health Outcomes Prevention and Evaluation 4 (HOPE 4) project: A successful community-based intervention to lower cardiovascular risk in people with hypertension.

Published in:

2020

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

Systolic blood pressure control prevents cognitive decline and slows development of white matter lesions in the brain: the SPRINT MIND study outcomes.

Published in:

2019

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

The PARAGON-Heart failure trial – another disappointment for heart failure patients with hypertension and preserved ejection fraction.

Published in:

2019

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE study.

Published in:

Blood Pressure, 2019, v. 28, n. 5, p. 317, doi. 10.1080/08037051.2019.1633905

By:

Larstorp, Anne C. K.;
Stokke, Ildri M.;
Kjeldsen, Sverre E.;
Hecht Olsen, Michael;
Okin, Peter M.;
Devereux, Richard B.;
Wachtell, Kristian

Publication type:

Article

The PARAGON Heart Failure trial – ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction.

Published in:

2019

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.

Published in:

2019

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension?

Published in:

2019

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

Association of left bundle branch block with new onset abnormal wall motion in treated hypertensive patients with left ventricle hypertrophy: the LIFE Echo Sub-study.

Published in:

Blood Pressure, 2019, v. 28, n. 2, p. 84, doi. 10.1080/08037051.2019.1569463

By:

Stokke, Ildri M.;
Li, Zhi Bin;
Cicala, Silvana;
Okin, Peter M.;
Kjeldsen, Sverre E.;
Devereux, Richard B.;
Wachtell, Kristian

Publication type:

Article

New data on antihypertensive drugs and risk of cancer: should we worry?

Published in:

2019

By:

Burnier, Michel;
Narkiewicz, Krzysztof;
Kjeldsen, Sverre E.;
Oparil, Suzanne

Publication type:

Editorial

Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study.

Published in:

Blood Pressure, 2018, v. 27, n. 5, p. 247, doi. 10.1080/08037051.2018.1507621

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Article

Renal denervation achieved by endovascular delivery of ultrasound in RADIANCE-HTN SOLO or by radiofrequency energy in SPYRAL HTN-OFF and SPYRAL-ON lowers blood pressure.

Published in:

2018

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Editorial

In memoriam: Alberto Zanchetti.

Published in:

2018

By:

Kjeldsen, Sverre E.;
Narkiewicz, Krzysztof;
Burnier, Michel;
Oparil, Suzanne

Publication type:

Obituary

New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden?

Published in:

2018

By:

Burnier, Michel;
Oparil, Suzanne;
Narkiewicz, Krzysztof;
Kjeldsen, Sverre E.

Publication type:

Editorial